Theratechnologies Inc (THTX) concluded trading on Wednesday at a closing price of $1.86, with 49.12 million shares of worth about $91.37 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 49.40% during that period and on March 26, 2025 the price saw a gain of about 20.78%. Currently the company’s common shares owned by public are about 45.98M shares, out of which, 19.10M shares are available for trading.
Stock saw a price change of 20.00% in past 5 days and over the past one month there was a price change of 2.48%. Year-to-date (YTD), THTX shares are showing a performance of 2.76% which increased to 46.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.08 but also hit the highest price of $2.18 during that period. The average intraday trading volume for Theratechnologies Inc shares is 192.53K. The stock is currently trading 17.04% above its 20-day simple moving average (SMA20), while that difference is up 13.00% for SMA50 and it goes to 28.82% higher than SMA200.
Theratechnologies Inc (NASDAQ: THTX) currently have 45.98M outstanding shares and institutions hold larger chunk of about 57.43% of that.
The stock has a current market capitalization of $45.01M and its 3Y-monthly beta is at 1.07. It has posted earnings per share of -$0.19 in the same period. It has Quick Ratio of 1.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for THTX, volatility over the week remained 10.31% while standing at 7.05% over the month.
Analysts are in expectations that Theratechnologies Inc (THTX) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 176.47% while it is estimated to increase by 61.54% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on November 17, 2022 offering an Overweight rating for the stock and assigned a target price of $9 to it. Coverage by Canaccord Genuity stated Theratechnologies Inc (THTX) stock as a Hold in their note to investors on July 29, 2021, suggesting a price target of $3 for the stock.
